Valrubicin

Catalog No.S9522

For research use only.

Valrubicin is a chemotherapy drug used to treat bladder cancer. Valrubicin is a chemotherapy agent, inhibits TPA- and PDBu-induced PKC activation with IC50s of 0.85 and 1.25 μM, respectively.

Valrubicin Chemical Structure

CAS No. 56124-62-0

Purity & Quality Control

Choose Selective PKC Inhibitors

Other PKC Products

Biological Activity

Description Valrubicin is a chemotherapy drug used to treat bladder cancer. Valrubicin is a chemotherapy agent, inhibits TPA- and PDBu-induced PKC activation with IC50s of 0.85 and 1.25 μM, respectively.
Targets
TPA-activated PKC [1]
(Cell-free assay)
PDBu-activated PKC [1]
(Cell-free assay)
0.85 μM 1.25 μM

Protocol (from reference)

Solubility (25°C)

In vitro

DMSO 100 mg/mL
(138.19 mM)
Ethanol 100 mg/mL
(138.19 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 723.64
Formula

C34H36F3NO13

CAS No. 56124-62-0
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01316874 Completed Drug: Valrubicin 800 mg Carcinoma in Situ|Bladder Cancer Endo Pharmaceuticals November 1993 Phase 2|Phase 3

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Valrubicin | Valrubicin ic50 | Valrubicin price | Valrubicin cost | Valrubicin solubility dmso | Valrubicin purchase | Valrubicin manufacturer | Valrubicin research buy | Valrubicin order | Valrubicin mouse | Valrubicin chemical structure | Valrubicin mw | Valrubicin molecular weight | Valrubicin datasheet | Valrubicin supplier | Valrubicin in vitro | Valrubicin cell line | Valrubicin concentration | Valrubicin nmr